Diagnostic delay in bronchiectasis: an Italian perspective.

https://bit.ly/46XMWAz.

Transient asymptomatic bradycardia and remdesivir in COVID-19 patients.

Background: COVID-19 is an infectious disease caused by a Coronavirus in humans, namely SARS-CoV-2, which has quickly become a global pandemic. The infection is responsible for a severe form of pneumonia, which may lead to lung failure and death. Among the therapeutic strategies, the antiviral agent remdesivir has become one of the most used drugs.

Point-of-care blood eosinophil count in a severe asthma clinic setting.

Background: One of the main severe asthma phenotypes is severe eosinophilic or eosinophilic refractory asthma for which novel biologic agents are emerging as therapeutic options. In this context, blood eosinophil counts are one of the most reliable biomarkers.

Objective: To evaluate the performance of a point-of-care peripheral blood counter in a patients with severe asthma.